Product NDC: | 63672-0051 |
Proprietary Name: | Levocetirizine dihydrochloride |
Non Proprietary Name: | Levocetirizine dihydrochloride |
Active Ingredient(s): | 5 mg/1 & nbsp; Levocetirizine dihydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63672-0051 |
Labeler Name: | Synthon Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090229 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101126 |
Package NDC: | 63672-0051-0 |
Package Description: | 87000 TABLET, FILM COATED in 1 DRUM (63672-0051-0) |
NDC Code | 63672-0051-0 |
Proprietary Name | Levocetirizine dihydrochloride |
Package Description | 87000 TABLET, FILM COATED in 1 DRUM (63672-0051-0) |
Product NDC | 63672-0051 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Levocetirizine dihydrochloride |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20101126 |
Marketing Category Name | ANDA |
Labeler Name | Synthon Pharmaceuticals, Inc. |
Substance Name | LEVOCETIRIZINE DIHYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |